192 related articles for article (PubMed ID: 1664514)
41. Comparative features of comedo and noncomedo ductal carcinoma in situ of the breast on fine-needle aspiration biopsy.
Malamud YR; Ducatman BS; Wang HH
Diagn Cytopathol; 1992; 8(6):571-6. PubMed ID: 1334826
[TBL] [Abstract][Full Text] [Related]
42. Cytological criteria for the diagnosis of intraductal hyperplasia, ductal carcinoma in situ, and invasive carcinoma of the breast.
Bofin AM; Lydersen S; Hagmar BM
Diagn Cytopathol; 2004 Oct; 31(4):207-15. PubMed ID: 15452908
[TBL] [Abstract][Full Text] [Related]
43. Preoperative aspiration cytology of breast tumors.
Eisenberg AJ; Hajdu SI; Wilhelmus J; Melamed MR; Kinne D
Acta Cytol; 1986; 30(2):135-46. PubMed ID: 3008470
[TBL] [Abstract][Full Text] [Related]
44. Intraductal breast cancer: review of 183 consecutive cases.
Cataliotti L; Distante V; Ciatto S; Bianchi S; Pacini P; Simoncini R; Rosselli Del Turco M; Cardona G; Falli F
Eur J Cancer; 1992; 28A(4-5):917-20. PubMed ID: 1326310
[TBL] [Abstract][Full Text] [Related]
45. Mucocele-like lesions of the breast: a benign cause for indeterminate or suspicious mammographic microcalcifications.
Farshid G; Pieterse S; King JM; Robinson J
Breast J; 2005; 11(1):15-22. PubMed ID: 15647073
[TBL] [Abstract][Full Text] [Related]
46. Stereotactic core-needle breast biopsy by surgeons: minimum 2-year follow-up of benign lesions.
Burns RP; Brown JP; Roe SM; Sprouse LR; Yancey AE; Witherspoon LE
Ann Surg; 2000 Oct; 232(4):542-8. PubMed ID: 10998652
[TBL] [Abstract][Full Text] [Related]
47. Heterogeneous risk profiles among B3 breast lesions of uncertain malignant potential.
Orsaria P; Grasso A; Carino R; Caredda E; Sammarra M; Altomare C; Rabitti C; Gullotta G; Perrone G; Pantano F; Buonomo OC; Altomare V
Tumori; 2020 Apr; 106(2):115-125. PubMed ID: 31451072
[TBL] [Abstract][Full Text] [Related]
48. Nucleolar organizer regions distribution in fine needle aspiration cytological smears from breast lesions.
Hasnan J; Jayaram G
Malays J Pathol; 1996 Jun; 18(1):35-41. PubMed ID: 10879223
[TBL] [Abstract][Full Text] [Related]
49. Atypical hyperplasia in the era of stereotactic core needle biopsy.
Brown TA; Wall JW; Christensen ED; Smith DV; Holt CA; Carter PL; Patience TH; Babu SS; Williard WC
J Surg Oncol; 1998 Mar; 67(3):168-73. PubMed ID: 9530887
[TBL] [Abstract][Full Text] [Related]
50. Ductal carcinoma-in-situ of the breast: fine-needle aspiration cytology of 12 cases.
Sneige N; White VA; Katz RL; Troncoso P; Libshitz HI; Hortobagyi GN
Diagn Cytopathol; 1989; 5(4):371-7. PubMed ID: 2558863
[TBL] [Abstract][Full Text] [Related]
51. Factors affecting the under-diagnosis of atypical ductal hyperplasia diagnosed by core needle biopsies - A 10-year retrospective study and review of the literature.
Co M; Kwong A; Shek T
Int J Surg; 2018 Jan; 49():27-31. PubMed ID: 29146271
[TBL] [Abstract][Full Text] [Related]
52. Lobular carcinoma in situ or atypical lobular hyperplasia at core-needle biopsy: is excisional biopsy necessary?
Foster MC; Helvie MA; Gregory NE; Rebner M; Nees AV; Paramagul C
Radiology; 2004 Jun; 231(3):813-9. PubMed ID: 15105449
[TBL] [Abstract][Full Text] [Related]
53. Mammographically detected breast lesions: clinical importance of cytologic atypia in stereotaxic fine-needle aspiration biopsy samples.
Mitnick JS; Vazquez MF; Feiner HD; Pressman P; Roses DF
Radiology; 1996 Feb; 198(2):319-22. PubMed ID: 8596824
[TBL] [Abstract][Full Text] [Related]
54. Lobular neoplasia at 11-gauge vacuum-assisted stereotactic biopsy: correlation with surgical excisional biopsy and mammographic follow-up.
Mahoney MC; Robinson-Smith TM; Shaughnessy EA
AJR Am J Roentgenol; 2006 Oct; 187(4):949-54. PubMed ID: 16985141
[TBL] [Abstract][Full Text] [Related]
55. Comparison of preoperative simultaneous stereotactic fine needle aspiration biopsy and stereotactic core needle biopsy in ductal carcinoma in situ of the breast.
Leifland K; Lundquist H; Lagerstedt U; Svane G
Acta Radiol; 2003 Mar; 44(2):213-7. PubMed ID: 12694110
[TBL] [Abstract][Full Text] [Related]
56. Fine needle aspiration cytology in young women with breast cancer: diagnostic difficulties.
Somani A; Hwang JS; Chaiwun B; Tse GM; Lui PC; Tan PH
Pathology; 2008 Jun; 40(4):359-64. PubMed ID: 18446625
[TBL] [Abstract][Full Text] [Related]
57. Risk of needle tract seeding of breast cancer: cytological results derived from core wash material.
Uematsu T; Kasami M
Breast Cancer Res Treat; 2008 Jul; 110(1):51-5. PubMed ID: 17674195
[TBL] [Abstract][Full Text] [Related]
58. Monoclonal antibody B72.3 as a diagnostic adjunct in fine needle aspirates of breast masses.
Lundy J; Lozowski M; Mishriki Y
Ann Surg; 1986 Apr; 203(4):399-402. PubMed ID: 3008673
[TBL] [Abstract][Full Text] [Related]
59. Breast cancer in Western Australia in 1989: III. Accuracy of FNA cytology in diagnosis.
Sterrett G; Harvey J; Parsons RW; Byrne MJ; Jamrozik K; Fitzgerald CJ; Dewar JM; Ingram DM; Sheiner H; Cameron F
Aust N Z J Surg; 1994 Nov; 64(11):745-9. PubMed ID: 7945080
[TBL] [Abstract][Full Text] [Related]
60. Breast fine needle aspiration cytology. Utility as a screening tool for clinically palpable lesions.
Costa MJ; Tadros T; Hilton G; Birdsong G
Acta Cytol; 1993; 37(4):461-71. PubMed ID: 8328240
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
